Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-glomerular basement membrane disease after alemtuzumab.

× No keyword cloud information.

25 in total

Review 1. Monoclonal antibodies as disease modifying therapy in multiple sclerosis.

Authors: Erin E Longbrake; Becky J Parks; Anne H Cross
Journal: Curr Neurol Neurosci Rep Date: 2013-11 Impact factor: 5.081

Review 2. Monoclonal antibodies in treatment of multiple sclerosis.

Authors: P S Rommer; A Dudesek; O Stüve; U K Zettl
Journal: Clin Exp Immunol Date: 2014-03 Impact factor: 4.330

3. Promising treatments of tomorrow for multiple sclerosis.

Authors: Daniel M Harrison; Peter A Calabresi
Journal: Ann Indian Acad Neurol Date: 2009-10 Impact factor: 1.383

Review 4. Basement membranes and autoimmune diseases.

Authors: Mary H Foster
Journal: Matrix Biol Date: 2016-08-02 Impact factor: 11.583

5. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors: Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal: J Am Soc Nephrol Date: 2011-08-25 Impact factor: 10.121

Review 6. [Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis].

Authors: C Warnke; B C Kieseier; U Zettl; H-P Hartung
Journal: Nervenarzt Date: 2009-04 Impact factor: 1.214

Review 10. Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.

Authors: Mary H Foster
Journal: Am J Physiol Renal Physiol Date: 2016-06-22

Anti-glomerular basement membrane disease after alemtuzumab.